Tanke Biosciences Corporation
TNBI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$633.75K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $633,748.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.01 |
| Beta | -1.05 |
| Outstanding Shares | 25,464,279 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -3.95 |
|---|---|
| PEG | 13.97 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Tanke Biosciences Corporation
130 employees
CEO: Vincent W. Renz Jr.
Tanke Biosciences Corporation (TNBI) is a company dedicated to the development, production, and sale of a diverse portfolio of animal nutrition and feed additive products through its various subsidiaries. The company organizes its busine...